Publicaciones en colaboración con investigadores/as de University of Pisa (4)

2019

  1. P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1